Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PET Imaging in Patients With Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765940
What this trial is testing

Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer

Who this might be right for
Prostate Cancer
RadAlliance Therapeutics, Inc 52
Not applicableLooking for participantsNCT06859203
What this trial is testing

A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-ligand PET

Who this might be right for
Biochemical Recurrence of Malignant Neoplasm of Prostate
Technical University of Munich 94
Very early researchStudy completedNCT04282824
What this trial is testing

Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer

Who this might be right for
Prostate Carcinoma
Jonsson Comprehensive Cancer Center 14
Large-scale testing (Phase 3)Study completedNCT02981368
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Progenics Pharmaceuticals, Inc. 385
Testing effectiveness (Phase 2)Study completedNCT03362359
What this trial is testing

Ga-68-PSMA-11 in High-risk Prostate Cancer

Who this might be right for
High-risk Prostate CancerProstate CancerProstate Cancer Metastatic+1 more
German Cancer Research Center 173
Testing effectiveness (Phase 2)WithdrawnNCT01132599
What this trial is testing

Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Research UK
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830212
What this trial is testing

Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm, Single-Center Study

Who this might be right for
Prostatic NeoplasmsProstate Cancer
Yong He 50
Testing effectiveness (Phase 2)Study completedNCT03606837
What this trial is testing

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging

Who this might be right for
Prostate Cancer
University Hospital, Bordeaux 14
Large-scale testing (Phase 3)Study completedNCT03822845
What this trial is testing

Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-Resistant
Michael Graham PhD, MD 6
Testing effectiveness (Phase 2)Study completedNCT03604757
What this trial is testing

68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks

Who this might be right for
Prostate Cancer
University Hospital, Bordeaux 22
Early research (Phase 1)Ended earlyNCT00975299
What this trial is testing

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers

Who this might be right for
Diagnostic Imaging
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT02004418
What this trial is testing

Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate Gland

Who this might be right for
Prostatic Neoplasms
AHS Cancer Control Alberta 21
Large-scale testing (Phase 3)Study completedNCT04838613
What this trial is testing

Study of Diagnostic Performance of [18F]CTT1057 in BCR

Who this might be right for
Prostatic NeoplasmsProstate CancerRecurrence
Novartis Pharmaceuticals 190
Not applicableActive Not RecruitingNCT05470699
What this trial is testing

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

Who this might be right for
Prostate Carcinoma
City of Hope Medical Center 34
Large-scale testing (Phase 3)Active Not RecruitingNCT05794906
What this trial is testing

Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 985
Large-scale testing (Phase 3)Looking for participantsNCT06276465
What this trial is testing

Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging

Who this might be right for
Prostatic Cancer, Castration-Resistant
UNICANCER 336
Not applicableStudy completedNCT01567800
What this trial is testing

Prostate Hypoxia FAZA

Who this might be right for
Prostate Cancer
University Health Network, Toronto 18
Large-scale testing (Phase 3)Looking for participantsNCT07649122
What this trial is testing

This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.

Who this might be right for
Prostate Cancer
Norroy Bioscience Co., LTD 232
Large-scale testing (Phase 3)UnknownNCT06011304
What this trial is testing

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
HTA Co., Ltd. 267
Testing effectiveness (Phase 2)Study completedNCT01774071
What this trial is testing

Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 19
Next Page